Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2

Hai-yun Li,Ning Gao,Cheng-yang Liu,Xiao-ling Liu,Feng Wu,Nini Dai,Jing Han,Qiu-yu Li

DOI: https://doi.org/10.3389/fimmu.2022.1011789

IF: 7.3

2022-09-12

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.918731.].

immunology

What problem does this paper attempt to address?

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Kaikai Yu,Bin Liu,Haotian Yu,Chengbiao Sun,Xuefeng Wang,Guorui Li,Mingxin Dong,Yan Wang,Jianxu Zhang,Na Xu,Wensen Liu

DOI: https://doi.org/10.3389/fcimb.2023.1264974

IF: 6.073

2023-08-24

Frontiers in Cellular and Infection Microbiology

Abstract:[This corrects the article DOI: 10.3389/fcimb.2023.1155293.].

immunology,microbiology
Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

Zhe-Kun Jia,Hai-Yun Li,Yu-Lin Liang,Lawrence A. Potempa,Shang-Rong Ji,Yi Wu

DOI: https://doi.org/10.3389/fimmu.2020.619847

IF: 7.3

2020-11-24

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2018.00234.].

immunology
Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Jingcheng Wu,Wenfan Chen,Jingjing Zhou,Wenyi Zhao,Yisheng Sun,Hanping Zhu,Pingping Yao,Shuqing Chen,Jianmin Jiang,Zhan Zhou

DOI: https://doi.org/10.3389/fphar.2020.646111

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2020.572249.].
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum to: Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein

Pengfei Pei,Hongbo Qin,Jialin Chen,Fengli Wang,Chengzhi He,Shiting He,Bixia Hong,Ke Liu,Renzhong Qiao,Huahao Fan,Yigang Tong,Long Chen,Shi-Zhong Luo

DOI: https://doi.org/10.1093/bib/bbab298

IF: 9.5

2021-07-17

Briefings in Bioinformatics

Abstract:Upon the original publication of this article, two author names were incorrectly given as ``Ren zhong Qiao'' and ``Yi-gang Tong''. These should read: ``Renzhong Qiao'' and ``Yigang Tong''. As well as this, separating semi-colons were missing from the keywords. These errors have now been corrected online.

biochemical research methods,mathematical & computational biology
Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity

Haijun Tang,Long Gao,Zhao Wu,Fang Meng,Xin Zhao,Yun Shao,Xiaohua Shi,Shigang Qiao,Jianzhong An,Xiaohong Du,F. Xiao-Feng Qin

DOI: https://doi.org/10.3389/fcimb.2021.813645

IF: 6.073

2021-11-29

Frontiers in Cellular and Infection Microbiology

Abstract:[This corrects the article DOI: 10.3389/fcimb.2021.720357.].

immunology,microbiology
Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity

Blanca Molins,Marc Figueras-Roca,Oliver Valero,Victor Llorens,Sara Romero-Vázquez,Oriol Sibila,Alfredo Adan,Carolina Garcia-Vidal,Alex Soriano

DOI: https://doi.org/10.3389/fimmu.2024.1447976

IF: 7.3

2024-06-22

Frontiers in Immunology

Abstract:This article is a correction to: C-reactive protein isoforms as prognostic markers of COVID-19 severity

immunology
Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4

Yingchi Zhao,Ming Kuang,Junhong Li,Ling Zhu,Zijing Jia,Xuefei Guo,Yaling Hu,Jun Kong,Hang Yin,Xiangxi Wang,Fuping You

DOI: https://doi.org/10.1038/s41422-021-00501-0

IF: 44.1

2021-04-27

Cell Research

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41422-021-00501-0

cell biology
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus Trvlps and Interact with Trvlp Elements.

Dong-Shan Yu,Tian-Hao Weng,Chen-Yu Hu,Zhi-Gang Wu,Yan-Hua Li,Lin-Fang Cheng,Nan-Ping Wu,Lan-Juan Li,Hang-Ping Yao

DOI: https://doi.org/10.3389/fmicb.2019.02975

IF: 5.2

2020-01-01

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2018.02724.].
Correction to “The SARS-COV-2 Spike Protein Binds Sialic Acids, and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device”

Alexander Baker,Sarah-Jane Richards,Thomas Congdon,Muhammad Hasan,Collette Guy,Alexander Zwetsloot,Angelo Gallo,Józef Lewandowski,Phillip Stansfeld,Anne Straube,Marc Walker,Simona Chessa,Giulia Pergolizzi,Simone Dedola,Robert Field,Matthew Gibson

DOI: https://doi.org/10.1021/acscentsci.1c00027

IF: 18.2

2021-01-14

ACS Central Science

Abstract:[This corrects the article DOI: 10.1021/acscentsci.0c00855.].

chemistry, multidisciplinary
Corrigendum: Editorial: the Mechanisms of Action of Anti-Sars-cov-2 Drugs

Zhong Wang,Vincenzo Brancaleone,Janet Sultana

DOI: https://doi.org/10.3389/fphar.2022.1065930

IF: 5.6

2022-01-01

Frontiers in Pharmacology

Abstract:CORRECTION article Front. Pharmacol., 07 November 2022Sec. Experimental Pharmacology and Drug Discovery Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1065930
Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

DOI: https://doi.org/10.1097/MS9.0000000000002497

2024-09-04

Abstract:[This corrects the article DOI: 10.1097/MS9.0000000000001601.].
Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics

Zunera Khalid,Ma Huan,Muhammad Sohail Raza,Misbah Abbas,Zara Naz,Arnaud John Kombe Kombe,Weihong Zeng,Hongliang He,Tengchuan Jin

DOI: https://doi.org/10.3389/fmicb.2022.1059437

IF: 5.2

2022-10-21

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.901848.].

microbiology
Erratum for Zhao et al., "Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1"

Kaitao Zhao,Zunhui Ke,Hongbing Hu,Yahui Liu,Aixin Li,Rong Hua,Fangteng Guo,Junfeng Xiao,Yu Zhang,Ling Duan,Xin-Fu Yan,Yong-Gui Gao,Bing Liu,Yuchen Xia,Yan Li

DOI: https://doi.org/10.1128/spectrum.01002-21

IF: 3.7

2021-08-20

Microbiology Spectrum

Abstract:Microbiology Spectrum, Ahead of Print.

microbiology
Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Xin-Jie Zhong,Cai-E Wang,Ya-Nan Li,Qi-Yun Zhang,Qian-Yun Sun

DOI: https://doi.org/10.1016/j.heliyon.2024.e33331

IF: 3.776

2024-06-27

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2024.e30969.].
Corrigendum: Galectin-9: A Suppressor of Atherosclerosis?

Jian Yu,Ruirui Zhu,Kunwu Yu,Yue Wang,Yan Ding,Yucheng Zhong,Qiutang Zeng

DOI: https://doi.org/10.3389/fimmu.2021.686592

IF: 7.3

2021-04-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.604265.].

immunology
Corrigendum: Interferon-α2b Treatment for COVID-19

Qiong Zhou,Virginia Chen,Casey P. Shannon,Xiao-Shan Wei,Xuan Xiang,Xu Wang,Zi-Hao Wang,Scott J. Tebbutt,Tobias R. Kollmann,Eleanor N. Fish

DOI: https://doi.org/10.3389/fimmu.2020.615275

IF: 7.3

2020-10-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.01061.].

immunology
Erratum to: "Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages" [Biochemistry (Moscow), 83, 982 (2018)]

A Ya Dunina-Barkovskaya,Kh S Vishnyakova,A O Golovko,A M Arutyunyan,L A Baratova,O V Batishchev,V A Radyukhin

DOI: https://doi.org/10.1134/S0006297918090158

Abstract:This corrects the article DOI: 10.1134/S0006297918080096.
Corrigendum to "Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region" [Biochem. Biophys. Rep. 31 (2022) 1-9/101284]

Morgan S Haines,Eduardo Ramirez,Kendall B E Moore,Jessica S Fortin

DOI: https://doi.org/10.1016/j.bbrep.2024.101775

2024-07-16

Abstract:[This corrects the article DOI: 10.1016/j.bbrep.2022.101284.].

Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2

Corrigendum: A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022

Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

Corrigendum: COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses.

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum to: Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein

Corrigendum: Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity

Corrigendum: C-reactive protein isoforms as prognostic markers of COVID-19 severity

Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus Trvlps and Interact with Trvlp Elements.

Correction to “The SARS-COV-2 Spike Protein Binds Sialic Acids, and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device”

Corrigendum: Editorial: the Mechanisms of Action of Anti-Sars-cov-2 Drugs

Erratum: Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review: Erratum

Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics

Erratum for Zhao et al., "Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1"

Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]

Corrigendum: Galectin-9: A Suppressor of Atherosclerosis?

Corrigendum: Interferon-α2b Treatment for COVID-19

Erratum to: "Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages" [Biochemistry (Moscow), 83, 982 (2018)]

Corrigendum to "Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region" [Biochem. Biophys. Rep. 31 (2022) 1-9/101284]